UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 142

of 'Treatment of relapsed or refractory chronic lymphocytic leukemia'

142
TI
Alemtuzumab in combination with high-dose methylprednisolone is a logical, feasible and highly active therapeutic regimen in chronic lymphocytic leukaemia patients with p53 defects.
AU
Pettitt AR, Matutes E, Oscier D
SO
Leukemia. 2006;20(8):1441. Epub 2006 Jun 1.
 
AD
PMID